Trastuzumab emtansine for residual invasive HER2-positive breast cancer - Minckwitz, Gunter von; Huang, Chiun-Sheng; Mano, Max S.; Loibl, Sibylle; Mamounas, Eleftherios P.; Untch, Michael; Wolmark, Norman; Rastogi, Priya; Schneeweiss, Andreas; Redondo, Andres; Fischer, Hans H.; Jacot, William; et al. (The New England journal of medicine, 2019)
This article was published on December 5, 2018